AZN vs. NVO: A Head-to-Head Stock Comparison
UpdatedHere’s a clear look at AZN and NVO, comparing key factors like performance, valuation metrics, dividends, and financial strength. It’s built for investors or anyone curious to see how these two stocks match up.
Company Overview
With AZN at 432.07 billion USD and NVO at 305.18 billion USD, their market capitalizations sit in the same ballpark.
With betas of 0.18 for AZN and 0.21 for NVO, both show similar volatility profiles relative to the overall market.
AZN and NVO are both ADRs—easy access for U.S. investors to foreign shares without dealing with overseas exchanges.
| Symbol | AZN | NVO |
|---|---|---|
| Company Name | AstraZeneca PLC | Novo Nordisk A/S |
| Country | GB | DK |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - General | Drug Manufacturers - General |
| CEO | Mr. Pascal Claude Roland Soriot D.V.M., M.B.A. | Mr. Lars Fruergaard Jorgensen |
| Price | 69.68 USD | 68.2 USD |
| Market Cap | 432.07 billion USD | 305.18 billion USD |
| Beta | 0.18 | 0.21 |
| Exchange | NASDAQ | NYSE |
| IPO Date | May 12, 1993 | April 30, 1981 |
| ADR | Yes | Yes |
Performance Comparison
This chart compares the performance of AZN and NVO over the past year by tracking the growth of an initial $10,000 investment in each (starting one year ago).
Hover over the lines to see the investment’s value and total return (%) at specific dates.
Data is adjusted for dividends and splits.
Valuation Metrics Comparison
For a detailed comparison of valuation metrics between AZN and NVO, please refer to the table below.
| Symbol | AZN | NVO |
|---|---|---|
| Price-to-Earnings Ratio (P/E, TTM) | 27.76 | 18.77 |
| Forward PEG Ratio (TTM) | 2.49 | 1.31 |
| Price-to-Sales Ratio (P/S, TTM) | 3.93 | 6.53 |
| Price-to-Book Ratio (P/B, TTM) | 5.26 | 14.17 |
| Price-to-Free Cash Flow Ratio (P/FCF, TTM) | 22.30 | 26.48 |
| EV-to-EBITDA (TTM) | 13.67 | 12.80 |
| EV-to-Sales (TTM) | 4.41 | 6.79 |
| EV-to-Free Cash Flow (TTM) | 25.04 | 27.55 |
Dividend Comparison
NVO stands out with a 2.58% dividend yield—around 85% above AZN’s 1.39%—highlighting its emphasis on generous payouts.
| Symbol | AZN | NVO |
|---|---|---|
| Dividend Yield (TTM) | 1.39% | 2.58% |
Financial Strength Metrics Comparison
This section dives into the financial resilience of AZN and NVO, spotlighting key metrics like liquidity, leverage, and debt coverage. Check out the standout observations below where notable differences or extremes pop up.
- With current ratios of 0.90 and 0.74, both AZN and NVO have less current assets than short-term liabilities, which could strain their working capital and force reliance on additional financing.
- Both AZN (quick ratio 0.70) and NVO (quick ratio 0.56) fall below 0.8, meaning their most liquid assets—excluding inventory—aren’t enough to meet short-term obligations. This could force them to rely on receivables, inventory turn, or external financing.
| Symbol | AZN | NVO |
|---|---|---|
| Current Ratio (TTM) | 0.90 | 0.74 |
| Quick Ratio (TTM) | 0.70 | 0.56 |
| Debt-to-Equity Ratio (TTM) | 0.77 | 0.86 |
| Debt-to-Assets Ratio (TTM) | 0.30 | 0.24 |
| Interest Coverage Ratio (TTM) | 7.95 | 17.84 |